Theodore W. Laetsch, MD
Associate Professor of Pediatrics (Oncology) at the Children's Hospital of Philadelphia
Inaugural Director, Very Rare Malignant Tumors Program, Children's Hospital of Philadelphia
Director, Developmental Therapeutics Program, Children's Hospital of Philadelphia
Clinical Competence Committee Member, Children's Hospital of Philadelphia
Co-chair, CHOP Data Use Committee: Policy Sub-committee, Children's Hospital of Philadelphia
Organizing PI, Precision Medicine for High Risk Pediatric Oncology Frontier Program, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
HUB for Clinical Collaboration
3500 Civic Center Blvd; Office 3527
Philadelphia, PA 19104
HUB for Clinical Collaboration
3500 Civic Center Blvd; Office 3527
Philadelphia, PA 19104
Email:
laetscht@chop.edu
laetscht@chop.edu
Publications
Education:
BS (Agriculture and Biosystems Engineering)
University of Arizona, Tucson, 2001.
MD (Medicine)
University of California, San Francisco, 2005.
Permanent linkBS (Agriculture and Biosystems Engineering)
University of Arizona, Tucson, 2001.
MD (Medicine)
University of California, San Francisco, 2005.
Selected Publications
Brizzolara-Dove S, Behl S, Segers B, Maple E, Caradonio O, Donnelly M, Robinson J, Stein M, Gutstein L, Bastianelli W, Crane J, Laetsch TW: The Precision Medicine Team at CHOP: Building Blocks for a Highly Effective Team. Precision Medicine Conference, San Fransisco, California - Abstract Mar 2024.Furth S, Laetsch TW: New Frontiers: Precision Medicine a "Unique Signature for Pediatric Cancer Patients. Bench to Bedside Podcast Mar 2024.
Ruiz J, Kelly RK, Aplenc R, Laetsch TW, Seif AE: Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship. Pediatric Blood and Cancer Feb 2024.
Grohar PJ, Behl S, Segers B, Levine W, Caradonio O, Gedminas J, Baldi J, Hurley R, Donnelly M, Brizzolara-Dove S, Robinson J, Rys M, Tartaglione M, Mascarenhas L, DuBois S, Glade-Bender Julia, Heske C, Chugh R, Crompton B, Maki B, Laetsch TW: Lurbinectedin in FET-Fused Tumors: a Phase I/II Open-Label Multicenter Trial. Stand Up to Cancer (SU2C) Scientific Summit, San Diego, California - Poster Presentation Jan 2024.
McNerney KO, Moskop A, Winestone LE, Baggott C, Talano JA, Schiff D, Rossoff J, Modi A, Verneris MR, Laetsch TW, Schultz L: Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Therapy Jan 2024.
McNerney KO, Naik S, Fabrizio VA, Talleur A, Lim SS, Dreyzin A, Baggott C, Vatsayan A, Prabhu S, Rossoff J, Pacenta HL, Philips C, Stefanski HE, Talano JA, Moskop A, Verneris M, Myers D, Karras NA, Bonifant C, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Baumeister S, Chinnabhandar V, Egeler E, Mavroukakis S, Curran KJ, Mackall CL, Laetsch TW, Schultz LM: Risk factors and outcomes for hematotoxicity following tisagenlecleucel for pediatric B-acute lymphoblastic leukemia. American Society of Hematology (ASH) Annual Meeting, San Deigo, California - Abstract Dec 2023.
Yang AT, Laetsch TW: Safety of current treatment options for NTRK fusion-positive cancers. Expert Opinion on Drug Safety Dec 2023.
Schultz KAP, Chintagumpala M, Piao J, Chen KS, Shah R, Gartrell RD, Christison-Lagay E, Pashnakar F, Berry JL, O'Neill AF, Vasta LM, Flynn A, Mitchell SG, Seynnaeve BK, Rosenblum J, Potter SL, Kamihara J, Rodriguez-Galindo C, Hawkins DS, Laetsch TW: Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective. EJC Paediatric Oncology Dec 2023.
Kelly R, Ruiz J, Aplenc R, Laetsch TW, Seif A: Differences in absolute neutrophil count eligibility criteria of pediatric phase I and phase I/II oncology clinical trials according to sponsorship. American Society of Hematology (ASH) Annual Meeting, San Deigo, California - Abstract Dec 2023.
Laetsch TW, Navid F, Weigel B, Fox E, Hawkins DS, Muscal JA, Juszczak-Kosela JA, Shang Z, Macy ME: Evaluation of Palbociclib in Combination With Topotecan and Cyclophosphamide in Pediatric Patients With Recurrent or Refractory Neuroblastoma. American Society of Hematology (ASH) Annual Meeting, San Deigo, California - Poster Presentation Dec 2023.